Journal of Legal Medicine
Georgia State University College of Law’s Center for Law, Health & Society and the American College of Legal Medicine have partnered on its publication, the Journal of Legal Medicine. Leslie Wolf, center director and Distinguished University Professor of Law, will serve as the new editor-in-chief. The Journal of Legal Medicine is an interdisciplinary, peer-reviewed, internationally circulated journal that focuses on the intersection of health law, science, and policy. In keeping with Georgia State Law’s and ACLM’s shared commitment to interdisciplinary exchange, the journal will accept short commentaries (up to 3,000 words) and articles (up to 7,500 words), although longer articles may also be published.Submit Articles Year-Round
Journal of Legal Medicine Inaugural Symposium: Solving America’s Drug Pricing Problem 2019
Upcoming Journal Events
Olmstead at Twenty: The Past and Future of Community Integration
August 8-9, 2019
Georgia State University College of Law
85 Park Place NE
Atlanta, GA 30303
2019 marks the 20th anniversary of Olmstead v. L.C. and E.W., the landmark U.S. Supreme Court decision hailed as the Brown v. Board of Education for people with disabilities. In Olmstead, the Court held that unjustified institutional isolation of people with disabilities is a form of unlawful discrimination under Title II of the Americans with Disabilities Act. Now, 20 years later, thousands of people have benefitted from the decision, as many states have increased funding for community services, but has the promise of Olmstead been realized for all? At the premiere legal Olmstead anniversary event, symposium speakers will explore the history of this groundbreaking civil rights decision, assess the current state of compliance, and imagine a path forward, where all people with disabilities have access to the supports they need to live full and meaningful lives in the community.
In collaboration with Atlanta Legal Aid Society and the Georgia Advocacy Office, Georgia State University invites legal scholars, advocates, attorneys and practitioners to submit proposals for the upcoming Olmstead at Twenty conference and to attend. Proposals on a wide variety of Olmstead issues are encouraged, including, but not limited to, the availability of and access to supported housing, segregation of students with disabilities in schools, the application of Olmstead to residents of nursing facilities, how Olmstead can be used to benefit people with mental illness who cycle in and out of jail, integrated supported employment, etc. Proposals may address gaps and areas that need to be addressed and/or innovative state initiatives, implementation and collaborations. Suggestions of other potential speakers and topics are also welcome. Please submit proposals by April 1, 2019 for consideration.
Registration for the conference is also open. Legal scholars, advocates, attorneys, practitioners and members of the community interested in legal issues related to community integration of persons with disabilities under Olmstead are invited to attend.
Email email@example.com with questions.Register Today! Download Agenda – Coming Soon Submit an Abstract
Past Journal Events
Inaugural Journal Symposium: Solving America’s Drug Pricing Problem
Jan. 24-25, 2019
Georgia State University College of Law
This symposium examined the possible legal and policy strategies to address spiraling prescription drug costs in America. Michelle M. Mello, J.D., Ph.D., a professor at Stanford University and co-author of the National Academies report Making Medicines Affordable: A National Imperative, delivered the keynote address. Two panel sessions featured experts discussing 1) state policies to combat drug pricing, such as price transparency, drug importation and anti-price gouging laws, as well as legal challenges to these measures; and 2) competition and innovation of law and policy in the market for prescription drugs, including anti-trust law, FDA oversight and patent law. The symposium concluded with a closed workshop for the speakers to reflect and identify priority areas for further research, advocacy or policy development to contain rising prescription drug prices.